Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Faster infusions for kids with IBD: a game changer for clinic visits?

NCT ID NCT06839820

First seen Apr 28, 2026 · Last updated Jun 17, 2026 · Updated 6 times

Summary

This study looks at whether giving infliximab over 30 minutes is as safe as the standard 60-minute infusion for children with inflammatory bowel disease (IBD). About 60 kids aged 1-17 who have already had at least 5 infusions will receive 8 infusions, alternating between the two speeds. The goal is to see if the shorter infusion causes just as few reactions and improves satisfaction for patients and families.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PATIENT SATISFACTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Akershus University Hospital

    Lørenskog, 1478, Norway

Conditions

The condition(s) this trial relates to.

inflammatory bowel disease irritable bowel syndrome Patient Satisfaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.